CZ88499A3 - Kombinace látek s antifungálním účinkem - Google Patents

Kombinace látek s antifungálním účinkem Download PDF

Info

Publication number
CZ88499A3
CZ88499A3 CZ99884A CZ88499A CZ88499A3 CZ 88499 A3 CZ88499 A3 CZ 88499A3 CZ 99884 A CZ99884 A CZ 99884A CZ 88499 A CZ88499 A CZ 88499A CZ 88499 A3 CZ88499 A3 CZ 88499A3
Authority
CZ
Czechia
Prior art keywords
spp
combination
inhibitor
combination according
antifungal
Prior art date
Application number
CZ99884A
Other languages
Czech (cs)
English (en)
Inventor
Kenneth F. Bartizal
George K. Abruzzo
Amy M. Flattery
Original Assignee
Merck And Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9620739.4A external-priority patent/GB9620739D0/en
Application filed by Merck And Co., Inc. filed Critical Merck And Co., Inc.
Publication of CZ88499A3 publication Critical patent/CZ88499A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1751—Bactericidal/permeability-increasing protein [BPI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CZ99884A 1996-09-12 1997-09-09 Kombinace látek s antifungálním účinkem CZ88499A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2632796P 1996-09-12 1996-09-12
GBGB9620739.4A GB9620739D0 (en) 1996-10-04 1996-10-04 Antifungal combination therapy

Publications (1)

Publication Number Publication Date
CZ88499A3 true CZ88499A3 (cs) 1999-10-13

Family

ID=26310166

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ99884A CZ88499A3 (cs) 1996-09-12 1997-09-09 Kombinace látek s antifungálním účinkem

Country Status (21)

Country Link
EP (1) EP0925070B1 (es)
JP (1) JP3288051B2 (es)
KR (1) KR100380871B1 (es)
CN (1) CN1235554A (es)
AT (1) ATE248625T1 (es)
AU (1) AU721334B2 (es)
CA (1) CA2265824C (es)
CY (1) CY2481B1 (es)
CZ (1) CZ88499A3 (es)
DE (1) DE69724626T2 (es)
DK (1) DK0925070T3 (es)
EA (1) EA002469B1 (es)
EE (1) EE03748B1 (es)
ES (1) ES2203819T3 (es)
IL (1) IL128870A0 (es)
NO (1) NO991207L (es)
NZ (1) NZ334446A (es)
PL (1) PL333282A1 (es)
PT (1) PT925070E (es)
SK (1) SK29999A3 (es)
WO (1) WO1998010782A1 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1056849C (zh) * 1994-11-08 2000-09-27 葛兰素惠尔康有限公司 抗真菌的粪壳菌素衍生物及其制备方法和其在制药中的应用
US6069126A (en) * 1996-09-12 2000-05-30 Merck & Co., Inc. Antifungal combination therapy
AUPQ066399A0 (en) * 1999-05-31 1999-06-24 Fujisawa Pharmaceutical Co., Ltd. Antifungal combination use
AUPQ462399A0 (en) * 1999-12-13 2000-01-13 Fujisawa Pharmaceutical Co., Ltd. New use
KR100680464B1 (ko) * 2000-06-28 2007-02-08 주식회사 하이닉스반도체 반도체 소자의 캐패시터 제조 방법
JPWO2002098463A1 (ja) * 2001-06-05 2004-09-16 財団法人新産業創造研究機構 抗真菌組成物
ES2368078T3 (es) 2005-04-07 2011-11-14 Toyama Chemical Co., Ltd. Composición farmacéutica y método que usa un agente antifúngico en combinación.
TWI385169B (zh) 2005-10-31 2013-02-11 Eisai R&D Man Co Ltd 經雜環取代之吡啶衍生物及含有彼之抗真菌劑
PT2070536E (pt) 2006-10-06 2012-03-06 Toyama Chemical Co Ltd Composição farmacêutica que contém um derivado de fenilamidina e processo para utilização dessa composição farmacêutica em associação com um agente antifúngico
TWI426918B (zh) 2007-02-12 2014-02-21 Merck Sharp & Dohme Ｉｌ-２３拮抗劑於治療感染之用途
WO2009129525A2 (en) * 2008-04-18 2009-10-22 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Antifungal and anti-cariogenic cellobio-oligosaccharides produced by dextransucrase
CN102274215B (zh) * 2010-06-10 2013-04-10 吉林大学 一种具有与氟康唑协同抗真菌作用的增效剂
CN102274217B (zh) * 2010-06-10 2013-04-10 吉林大学 三氯生作为抗真菌药物氟康唑增效剂的新用途
CN102274216B (zh) * 2010-06-10 2013-04-10 吉林大学 一种提高氟康唑抗真菌作用的增效剂
WO2012060448A1 (ja) 2010-11-05 2012-05-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗真菌剤としての併用医薬組成物
JP2014518878A (ja) * 2011-05-24 2014-08-07 バイエル クロップサイエンス エルピー ポリエン系殺菌剤と非リボソーム型ペプチドの相乗的組み合わせ及び関連する使用方法
CN102319326A (zh) * 2011-07-23 2012-01-18 李玮 一种治疗脚癣的浸药卫生纸
CN114652836B (zh) * 2022-03-25 2023-06-20 山东大学 T3ss小分子抑制剂及其筛选方法和应用
CN116473985A (zh) * 2023-03-29 2023-07-25 暨南大学 一种多烯类抗真菌药物组合物及其应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5378804A (en) * 1993-03-16 1995-01-03 Merck & Co., Inc. Aza cyclohexapeptide compounds

Also Published As

Publication number Publication date
SK29999A3 (en) 2000-02-14
JP3288051B2 (ja) 2002-06-04
PT925070E (pt) 2003-12-31
IL128870A0 (en) 2000-06-01
CA2265824C (en) 2004-11-09
ES2203819T3 (es) 2004-04-16
EE9900088A (et) 1999-10-15
CN1235554A (zh) 1999-11-17
WO1998010782A1 (en) 1998-03-19
EA199900283A1 (ru) 1999-08-26
KR100380871B1 (ko) 2003-04-18
KR20000036054A (ko) 2000-06-26
EE03748B1 (et) 2002-06-17
NO991207L (no) 1999-05-11
ATE248625T1 (de) 2003-09-15
NZ334446A (en) 2000-11-24
DK0925070T3 (da) 2003-12-01
JP2000503675A (ja) 2000-03-28
EP0925070B1 (en) 2003-09-03
DE69724626D1 (de) 2003-10-09
DE69724626T2 (de) 2004-07-29
AU4339297A (en) 1998-04-02
AU721334B2 (en) 2000-06-29
CY2481B1 (en) 2005-06-03
CA2265824A1 (en) 1998-03-19
EA002469B1 (ru) 2002-06-27
PL333282A1 (en) 1999-11-22
NO991207D0 (no) 1999-03-11
EP0925070A1 (en) 1999-06-30

Similar Documents

Publication Publication Date Title
CZ88499A3 (cs) Kombinace látek s antifungálním účinkem
Galgiani Fluconazole, a new antifungal agent
Deresinski et al. Caspofungin
Ryder et al. Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species
Wagner et al. The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications
Hoang Caspofungin acetate: an antifungal agent
Jarvis et al. Micafungin
US6069126A (en) Antifungal combination therapy
Allendoerfer et al. Combined therapy with fluconazole and flucytosine in murine cryptococcal meningitis
Sugar et al. Interactions of itraconazole with amphotericin B in the treatment of murine invasive candidiasis
Joseph et al. Micafungin: a new echinocandin antifungal
Nosanchuk Current status and future of antifungal therapy for systemic mycoses
US7375081B2 (en) Therapeutic combination of a pneumocandin derivative and an antifungal agent
Dodds et al. Antifungal pharmacodynamics: review of the literature and clinical applications
Harari Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients
Rosato et al. In vitro synergy testing of anidulafungin with fluconazole, tioconazole, 5-flucytosine and amphotericin B against some Candida spp.
Zaas et al. Micafungin: the US perspective
CA2433652A1 (en) Active metabolite of antifungal compound
MXPA99002401A (es) Terapia de combinacion antimicotica
Saravolatz et al. Caspofungin
Morrison et al. Comparative effects of cilofungin and amphotericin B on experimental murine candidiasis
Johnson et al. Echinocandins for prevention and treatment of invasive fungal infections
Karthaus et al. Second‐line treatment in invasive mould infections
ES2732941T3 (es) Oleilfosfocolina para el tratamiento de la micosis
Pereira et al. Antifungal Therapy in The ICU: The Bug, the Drug, and the Mug

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic